Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients

Completed · Phase 2 · Has a placebo group

Conditions studied: Allergic Conjunctivitis

In brief

The purpose of this study is to study the safety and efficacy of bepotastine besilate ophthalmic solution in allergic conjunctivitis patients.

Key facts

Study ID

NCT01174823

Run by

Bausch & Lomb Incorporated

People needed

245

Starts

2010-06-01

Expected to finish

2010-12-01

Last updated by the study team

2020-09-14

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects 12 years of age and older with 2-year history of allergic conjunctivitis

You may not qualify if…

• No active ocular or nasal infection

Where it is running

• ISTA Pharmaceuticals, Inc. — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.